Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Navigant Consulting, Inc.
New study identifies leading Medicare reform factors
June 26th, 2004
Navigant Consulting, Inc., (NYSE:NCI) announced that its Front Line Strategic Market Reports analysts have concluded a study entitled "Medicare Reform Overview: Impact on Pharmaceuticals" that provides a detailed analysis of the Medicare Prescription Drug Improvement and Modernization Act (MMA) and its ramifications on the U.S. pharmaceutical industry. "Medicare and Medicaid are currently facing difficult challenges to provide adequate healthcare coverage for their beneficiaries due to increasing enrollment rates and the rising costs of therapeutics," said Kenneth Smith, principal for navigant consulting. "The MMA presents various measures to adjust Medicare's current...
Source: Law & Health Weekly (2004-06-26)
|
